Piramal Pharma Share Price Target 2025, 2030, 2040, 2050

Byshareprice-target.com

Piramal Pharma is a Pharmaceutical company in West Bengal that generally makes and sells medicine. The company was established in 1988 as part of the Piramal Group. With great effort and hard work, it has become a strong brand today.

https://www.piramalpharma.com/

What is Piramal Pharma Ltd BOM: 543635?

Piramal Pharma Limited is an Indian company that produces and sells various types of medicines. The company develops and manufactures drugs, sells generic medicines to hospitals, and sells over-the-counter health products in India. Most of its money comes from North America, with the rest coming from Europe, India, Japan, and other countries.

Piramal Pharma Share Price Target Tomorrow

This share gave good returns on the Indian stock market. In the shorter time frame, it falls a bit. So for the shorter trading, you should wait until it shows a bullish moment.

Track all markets on TradingView
YearMinimum PriceMaximum Price
2024-10+21

Piramal Pharma Share Price Target 2025

Piramal Pharma started in 1984 and has grown worldwide. After separating from Piramal Enterprises, its stock went down a bit. But from the previous year the company recovering very fast. The company reached an all-time high in 2024 and is expected to make much more profit in the upcoming months. By 2025, its share price target would be ₹326, as per our analysis.

As per our analysis, its price will be between ₹158 and ₹326 in 2025.

YearMinimum Price (Rs)Maximum Price (Rs)
2025158326
MonthMinimum Price  (Rs)Maximum Price (Rs)
January205267
February180240
March174245
April167256
May158263
June171270
July178277
August190281
September198291
October218300
November240314
December261326

Piramal Pharma Share Price Target 2026

The Company started in 1984 and has expanded to many overseas countries. The company is valued at approximately Rs 112 billion. After separating from Piramal Enterprises, its stock saw a small drop, but till now the company has broken its all-time high price range. For the long term, it is the best time to invest according to our analysis. It is one of the top CDMO(Contract Development and Manufacturing Organization) companies in the area, with many customers from different parts of the world. In 2026, its share price target would be ₹664 as per our expert’s advice.

In 2026, its price would be between ₹200 to ₹664 according to our expert’s prediction.

YearMinimum Price (Rs)Maximum Price (Rs)
2026200664
MonthMinimum Price  (Rs)Maximum Price (Rs)
January326540
February430467
March345380
April267288
May200256
June234293
July276367
August334390
September367473
October420560
November490610
December589664

Share Price Target 2027

It is making big efforts to grow its business in different markets and countries. The company is putting more money into research to create better medicines and healthcare products. By developing a wide range of products and expanding its reach, it is working towards increasing its sales and profits over time. These strategies are likely to help the company become even stronger in the coming years. This makes a good choice for investors who are looking for long-term growth in their investments. In 2027, its share price target would be ₹760 as per our analysis.

Its share price would be between ₹260 to ₹760 in 2027, as per our analysis.

YearMinimum Price (Rs)Maximum Price (Rs)
2027260760
MonthMinimum Price  (Rs)Maximum Price (Rs)
January589681
February430490
March334374
April260310
May287387
June357432
July390478
August451520
September486590
October530631
November590690
December674760

Share Price Target 2028

The company keep expanding its range of healthcare products and services to reach more people in different countries. It is also working on building partnerships with other companies and buying smaller businesses to help it grow faster.  A large amount of revenue comes from its advanced generic medicines and development of new, innovative healthcare products. These efforts should help the company grow its business and improve its profits. In 2028, its share price target would be ₹870 as per our analysis.

Its share price would be between ₹320 to ₹870 in 2028.

YearMinimum Price (Rs)Maximum Price (Rs)
2028320870
MonthMinimum Price  (Rs)Maximum Price (Rs)
January674787
February530587
March430478
April456490
May470530
June488569
July521591
August568667
September623680
October654730
November680810
December790870

Share Price Target 2029

The company is highly focused on research and development, which means it is always working to create better medicines and improve healthcare solutions. By entering new markets and expanding into different regions, It is likely to reach more customers and grow its business. In addition to R&D, the company is also improving its internal processes, making it more efficient and profitable. These combined efforts are expected to boost the company’s earnings and help its stock price rise significantly over time. In 2029, its share price target would be ₹960 as per our prediction.

By our analysis, its share price would be between ₹390 to ₹960 in 2029.

YearMinimum Price (Rs)Maximum Price (Rs)
2029390960
MonthMinimum Price  (Rs)Maximum Price (Rs)
January790889
February630671
March563589
April420472
May390490
June454556
July527587
August568680
September630768
October730835
November790897
December860960

Piramal Pharma Share Price Target 2030

The company has a strong track record in buying and combining businesses, which will help the company grow and compete in the pharmaceutical market. They do business in the US, Europe, and Japan which helps protect them from relying too much on one place. Also, the company is trying to add more products, improve its operations, and enter new markets. The growth of its complex generics business and more demand for its healthcare products should boost profits. By 2030 its share price target would be ₹1077 as per our prediction.

Its share price will be between ₹450 to ₹1077 by 2030 as per our analysis.

YearMinimum Price (Rs)Maximum Price (Rs)
20304501077
MonthMinimum Price  (Rs)Maximum Price (Rs)
January860960
February735790
March624656
April537568
May450480
June460570
July530687
August642746
September705830
October787920
November8871023
December9931077

Share Price Target 2040

The company focuses of keep inventing effective medicines by inventing a good amount into research and development (R&D). Also, the company is expanding very rapidly by owning small companies and opening new branches which boosts its sales and profits. The company always focus on improving its quality to reach more consumers. By 2040, its share price target would be ₹2560 as per our expert’s analysis.

In 2040, its share price would be between ₹2028 to ₹2560 according to our expert analysis.

YearMinimum Price (Rs)Maximum Price (Rs)
204020282560
MonthMinimum Price  (Rs)Maximum Price (Rs)
January20282070
February20462120
March20872146
April21212178
May21462215
June21872246
July22102268
August22462290
September22702368
October23102458
November24172490
December24782560

Share Price Target 2050

The company’s focus on innovation and ability to offer high-quality, affordable pharmaceutical products will keep the company one step ahead form its competitors. Also, it partnering with other pharmaceutical companies and buying smaller companies which will strengthen its market position. These strategies could allow the company to expand its products and distribution, which would help increase its share price over time. By 2050, its share price target would be ₹5387 according to the technical analysis and market sentiments.

Its share price would be between ₹4844 to ₹5387 in 2050, as per our deep analysis.

YearMinimum Price (Rs)Maximum Price (Rs)
205048445387
MonthMinimum Price  (Rs)Maximum Price (Rs)
January48444925
February48784957
March48904990
April49545057
May50105122
June50785178
July51325190
August51545210
September51785230
October51905265
November52285310
December52875387

Should I Buy Piramal Pharma Stock?

YearMinimum Price (Rs)Maximum Price (Rs)
2025158326
2026200664
2027260760
2028320870
2029390960
20304501077
204020282560
205048445387

The company’s recent financial results show good growth potential. It has seen an increase in revenue and net income, which is a positive sign. It also has a stable profit margin and improved cash flow, which makes it attractive for investors. While it has some debt, its strong revenue and healthy cash reserves help balance this. So overall, it looks like a great option for long-term investors looking for growth and value.

Piramal Pharma Earning Results

Mcap Full (Cr.)32,513.97
EPS4.85
CEPS6.43
ROE9.16
TTQ (Lakh)1.90
Turnover (Cr.)4.67
Face Value10.00
Cash EPS1.99
OPM %27.97
NPM %16.35
EPS1.59
Net Profit(Cr.)210.06
Revenue(Cr.)1,284.39

Key Metrics

TTM PE RatioPB RatioDividend YieldSector PESector PBSector Div Yld
711.684.080.05%50.396.410.52%

Peers & Comparison

StockPE RatioPB RatioDividend Yield
Piramal Pharma Ltd1,810.364.080.05%
Sun Pharmaceutical Industries Ltd46.616.650.73%
Cipla Ltd29.174.490.87%
Torrent Pharmaceuticals Ltd70.1416.950.82%

Is Piramal Pharma Stock Good to Buy? (Bull case & Bear case)

Bull Case:

  • Its revenue and profits increase over time, which is a good sign for the future.
  • The pharmaceutical industry is expected to grow more in future.
  • The company is spending a lot on research and development.
  • With operations in over a hundred countries, it has a diverse market, which reduces risk.
  • The company Improves cash flow which helps the company invest and manage its debt better.

Bear Case:

  • The company has a lot of debt, which could be risky if profits go down.
  • While stable, its profit margin might be lower than some competitors, affecting long-term earnings.
  • Depends on launching new products can be problematic if not attract consumers.

Conclusion

For the listing time of this stock, it faced a bearish movement in the stock market because it got separated from the Piramal group but soon it recovered and at the current time it broke its all-time high price level. In this article, we have shared much more information like this which will help you to make a good decision so read the whole article to know about this stock.

FAQs

For our recommendation it is the perfect time as it broke its all-time high price level, you can take it when it took a little weaker retracement.

The pharmaceutical industry is expected to grow, and Piramal Pharma is investing in research and development, which could lead to new products and increased revenue.

Its P/E ratio is 32.92(October 26, 2024)

Similar Stocks